FIELD: chemistry.
SUBSTANCE: invention refers to compounds of formula (I), as well as to pharmaceutical compositions and use.
EFFECT: technical result is obtaining novel compounds having TAAR1 activity.
11 cl, 1 tbl, 106 ex
Title | Year | Author | Number |
---|---|---|---|
APOPTOSIS INDUCING AGENTS FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES | 2011 |
|
RU2568611C2 |
NOVEL CYCLOPENTANE DERIVATIVES | 2010 |
|
RU2572555C2 |
CROSS-LINKED ARTIFICIAL NUCLEIC ACID ALNA | 2019 |
|
RU2820226C2 |
SUBSTITUTED DIAMINO-CARBOXAMIDE AND DIAMINO-CARBONITRILE PYRIMIDINE DERIVATIVES, THEIR COMPOSITIONS AND METHODS OF TREATMENT USING THEM | 2012 |
|
RU2625309C2 |
INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZOISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, PREPARING AND USING THEM | 2006 |
|
RU2450003C2 |
SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE DERIVATIVES OF PYRIMIDINES, COMPOSITIONS THEREOF AND METHODS OF TREATING USE THEREOF | 2012 |
|
RU2697712C2 |
SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
AMIDE DERIVATIVES OF PYROSOL | 2015 |
|
RU2658827C2 |
METHOD FOR PREDICTING THE THERAPEUTIC EFFECT OF AN LSD 1INHIBITOR BASED ON THE INSM1 EXPRESSION | 2018 |
|
RU2789449C2 |
Authors
Dates
2019-08-16—Published
2015-07-29—Filed